The world of medical cannabis is constantly changing – stay up to date with the latest law changes, clinical breakthroughs, and more with Curaleaf Clinic.
Attention-Deficit Hyperactivity Disorder – commonly referred to by the abbreviation “ADHD” – is a neurodevelopmental disorder that is ...
The Japanese Society of Neuropsychopharmacology has today (12th December 2022) awarded the Topic Award 2022 to Sapphire Medical ...
Cannabis has now been legalised for medicinal purposes in a number of countries and jurisdictions around the world. ...
Plants have been used in medicine for thousands of years, with many active ingredients in various species having ...
In November 2018, the UK government officially rescheduled cannabis, allowing for its medicinal utilisation under specific circumstances. The ...
Despite the legalisation of medical cannabis in 2018, experts have warned that there is still inadequate education on ...
Curaleaf Pharmacy and Sapphire Medical are committed to engaging with patients and families, listening to feedback, and together ...
Tourette’s Syndrome (TS), also known as Gilles de la Tourette’s Syndrome, is a neurodevelopmental disorder that is largely ...
Over-the-counter (OTC) CBD products have become increasingly prevalent in the UK and globally. At the same time, access ...
Sapphire Clinics, the UK’s leading medical cannabis clinic and highest rated by the Care Quality Commission, is today ...
Musculoskeletal (MSK) conditions are among the most common causes of disability in the UK, with estimates indicating that ...
A new study published in the Journal of Cannabis Research reveals that a significant proportion of the population ...
